Prichard v. Bayer Healthcare Pharmaceuticals, Inc. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Prichard v. Bayer Healthcare Pharmaceuticals, Inc.

Sort by

Viewing results 1‒25 of 77

Drug prices
US drugmakers withdraw from NHS pricing agreement as costs soar
...AbbVie and Eli Lilly have withdrawn from the deal after the German conglomerate Bayer’s pharmaceutical chief executive told the Financial Times on Monday that it was reducing its UK footprint and cutting...
January 16, 2023
FT AlphavilleCoronavirus
The ESG case for the Oxford/AstraZeneca vaccine
...over, and poorer countries whose governments are stretched to secure doses for healthcare workers and the most vulnerable....
December 23, 2020
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Coronavirus
US hospitals panic-buy drugs ahead of coronavirus influx
...Bayer, the German pharmaceutical group, also said it would donate 3m of its malaria tablets, but as they are not approved in the US, they need an emergency authorisation from the FDA....
March 21, 2020
The Long ViewMichael Mackenzie
The coming earnings season could bring lofty stocks down to earth
...The prospect of much lower bond yields — and, crucially, the expectation that central banks will contain any sharp rise — has encouraged investors to boost their exposure to the technology and healthcare...
July 11, 2020
Mergers & Acquisitions
JPMorgan Chase set to scoop record fee for Allergan sale
...The pharmaceutical and healthcare sectors have been among the most active with $479bn worth of transactions announced....
August 13, 2019
News in-depthThe Big Read
The Apple effect: Germany fears being left behind by Big Tech
...healthcare”, in which technology is leveraged, on-demand, to create medication specific to the individual....
January 29, 2020
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
News in-depthThe Big Read
J&J: The next target of anger over America’s opioid crisis?
...It was this statement of corporate social responsibility — crafted decades before the term became overused PR — which he said had guided the world’s largest healthcare company to become a solid, long-term...
September 5, 2019
GSK PLC
GlaxoSmithKline to break up after striking Pfizer joint venture
...That puts it ahead of its nearest competitors Johnson & Johnson, Sanofi and Bayer, which hold about 4 per cent market shares each....
December 19, 2018
News in-depthThe Big Read
Quantum computing: the power to think outside the box
...Pharmaceutical groups, which might see similar benefits from quantum technology in the long term, are still on the sidelines....
September 3, 2018
News in-depthUS & Canadian companies
GSK’s move for Pfizer’s consumer arm divides market
...Reckitt cited financial discipline for quitting the two-horse race, as it also did in 2014, when it withdrew from bidding for the healthcare unit of Merck of the US, leaving Germany’s Bayer to clinch the...
March 22, 2018
Special Report50 Ideas to Change the World
Liver success holds promise of 3D organ printing
...This fourth tranche of 30 ideas (listed below) is about the latest advances in healthcare. The fifth and final chapter, looking at Earth and the universe, will be published on March 29, 2018....
March 5, 2018
LexUS & Canadian companies
Pfizer: shelf medication Premium content
...In 2014, Bayer paid seven times sales to German peer Merck in a $14bn deal....
October 10, 2017
US & Canadian companies
Pfizer weighs sale of consumer health business
...Pfizer has said it is looking to sell or spin off its consumer healthcare business in a move that could fetch up to $14bn of cash for the pharmaceuticals group and set off a flurry of dealmaking....
October 10, 2017
News in-depthThe Big Read
Drug prices: Tweaking the formula
...But Alexander Moscho, UK head of Bayer, the German drugmaker, says the qualy system is not flexible enough for the new world of personalised medicines....
April 25, 2016
US & Canadian companies
Medivation agrees to $10bn takeover talks
...The former Pfizer and Bayer executive has made dealmaking a key pillar of his strategy to strengthen the pharmaceutical company since taking over last year....
July 5, 2016
FT Live
Global Private Banking Awards 2024
Celebrating excellence in wealth management
Thursday, 7 NovemberThe Landmark London, London, UK
LexPharmaceuticals sector
Sanofi/Boehringer: swap shop
...In pharmaceuticals at least, it is making a comeback....
December 15, 2015
News in-depthUS & Canadian companies
Investor calls for big pharma to slim down grow louder
...Some of the world’s biggest pharmaceuticals groups are facing calls to break up their diversified businesses in favour of greater focus as shareholders push for higher returns on investment....
February 1, 2016
UK companies
Pharma groups eye healthy returns from animal drugs market
...Jeffrey Holford, analyst at Jefferies, has touted Bayer as another “logical and motivated” potential acquirer....
July 1, 2015
Currencies
Weak euro lifts European drugmakers
...Consumer healthcare was among Bayer’s strongest sources of growth after its $14bn acquisition of over-the-counter medicines from Merck of the US last year....
April 30, 2015
US & Canadian companies
Shire Pharmaceuticals eyes the big league with Baxalta bid
...Shire revealed it had approached Baxalta in early July, one day after the Illinois-based company had completed its spin-off from Baxter, the bigger US healthcare group....
August 4, 2015
US & Canadian companies
No end in sight to wave of pharma dealmaking
...Since the start of last year, pharmaceuticals companies have agreed $462bn of mergers and acquisitions — greater than the gross domestic product of Austria....
April 26, 2015
European companies
Sanofi appoints Brandicourt as CEO
...Dr Brandicourt is a Paris-educated medic who rose through the ranks of Pfizer before taking charge of Bayer’s healthcare division in 2013....
February 19, 2015
US & Canadian companies
Ackman’s Pershing Square secures seat on Zoetis board
...Pfizer spun off Zoetis in an initial public offering priced at $26 per share in January 2013, as part of its own plan to concentrate on human pharmaceuticals....
February 4, 2015
US & Canadian companies
AbbVie joins the pharma chain reaction
...This greater willingness to make clear choices about strategic priorities has been evident in deals such as Bayer’s $14.2bn acquisition of Merck’s consumer healthcare division last year — a transaction that...
March 6, 2015
US & Canadian companies
Superbug threat drives $9.5bn Merck deal
...For Merck, the deal underlines a sharper focus on acute hospital care, one of four areas of focus it identified when it sold its consumer healthcare business to Germany’s Bayer for $14.2bn in May....
December 8, 2014

Previous pagePage 1 of 4Next page